Whitfield Advises AmbioPharm on Merger with CordenPharma
Overview
AmbioPharm and CordenPharma were to combine, according to the source announcement concerning two contract development and manufacturing businesses serving pharmaceutical customers.
Ownership background
The source identifies Carlyle as AmbioPharm's sponsor and Astorg as CordenPharma's owner. No merger valuation is disclosed in the announcement.
Manufacturing locations
AmbioPharm develops and produces peptide active ingredients, with facilities in North Augusta, South Carolina, and Shanghai.
Advisory participants
The listed corporate advisers include Laura Steinke, Gregory Scott and David Higgins. Sam Sherwood, Natasha Smith and Aman Nath are named for finance, with Adam Kool and Patrick Nolan for tax.
